OncoMate MSI Dx Analysis System is a PCR-based assay designed to evaluate MSI status in tumor tissue
With milestone-linked funding of Rs. 5–25 crore per project (and up to Rs. 50 crore in exceptional cases), the Mission will support projects that bring impactful MedTech solutions to market
BIL also holds an option to increase its equity stake by an additional 15%
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Subscribe To Our Newsletter & Stay Updated
